Structural Formula (Amlodipine Besylate Tablet 01)
Amlodipine Besylate
Product Images NDC 10135-526
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 10135-526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine Besylate versus Placebo)
This appears to be statistical output related to a study. It includes a P-value, Hazard Ratio, and confidence interval. It also includes numbers listed under "Evert Rate" and what appears to be a timeline labeled "Time (Months)." However, there is not enough information or context to provide a more specific description of the study or its findings.*
Figure 2 – Effects On Primary Endpoint Of Amlodipine Besylate Versus Placebo Across Sub- Groups (Amlodipine Besylate Tablet 03)
Marlexamlodipine Besylate Tablets2.5 mg*rx Only500 Tablets (Amlodipine Besylate Tablet 04)
Marlexamlodipine Besylate Tablets5 mg*rx Only500 Tablets (Amlodipine Besylate Tablet 05)
This seems to be a label for a prescription medication called Amlodipine Besylate. It is indicated for the treatment of hypertension and angina. The strength of the dosage is not available. The label also indicates it is only available with a prescription and is manufactured by a company called PharmaST.*
Marlexamlodipine Besylate Tablets10 mg*rx Only1000 Tablets (Amlodipine Besylate Tablet 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
